Increased plasma soluble thrombomodulin levels in cardioembolic stroke
Soluble thrombomodulin (sTM) has been proposed as a potential marker of ischemic stroke. Results from previous studies remain controversial among different populations. We performed an analysis of plasma levels of sTM in Thai patients with acute ischemic stroke and determined whether sTM levels corr...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/14782 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.14782 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.147822018-06-11T12:10:12Z Increased plasma soluble thrombomodulin levels in cardioembolic stroke Permphan Dharmasaroja Pornpatr A. Dharmasaroja Prasert Sobhon Mahidol University Faculty of Medicine, Thammasat University Medicine Soluble thrombomodulin (sTM) has been proposed as a potential marker of ischemic stroke. Results from previous studies remain controversial among different populations. We performed an analysis of plasma levels of sTM in Thai patients with acute ischemic stroke and determined whether sTM levels correlate with stroke subtypes, severity, and risk factors. Ninety-three patients and 76 controls were enrolled. Blood samples were obtained within 24 hours after stroke onset. Plasma sTM levels, measured using quantitative enzyme-linked immunosorbent assay, were significantly higher in patients than controls (P < .005), with the mean ±standard deviation (SD) levels of 3.08 ± 1.05 and 2.57 ± 1.15 ng/mL, respectively. Plasma levels of sTM in patients with cardioembolic subtype were significantly higher than in patients with other stroke subtypes, with the mean ± SD levels of 3.79 ± 1.26, 2.38 ± 0.68 (P < .009), and 2.38 ± 0.44 (P < .05) ng/mL for cardioembolism, large artery atherosclerosis, and small artery occlusion, respectively. Plasma sTM levels were not associated with stroke severity and risk factors of stroke; however, there was a slight relationship between high sTM levels and the presence of atrial fibrillation in the patient group. In conclusion, plasma sTM levels were increased in Thai patients with cardioembolic stroke and may be a potential marker during the acute phase. © 2012 The Author(s). 2018-06-11T05:10:12Z 2018-06-11T05:10:12Z 2012-06-01 Article Clinical and Applied Thrombosis/Hemostasis. Vol.18, No.3 (2012), 289-293 10.1177/1076029611432744 19382723 10760296 2-s2.0-84860755199 https://repository.li.mahidol.ac.th/handle/123456789/14782 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84860755199&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Permphan Dharmasaroja Pornpatr A. Dharmasaroja Prasert Sobhon Increased plasma soluble thrombomodulin levels in cardioembolic stroke |
description |
Soluble thrombomodulin (sTM) has been proposed as a potential marker of ischemic stroke. Results from previous studies remain controversial among different populations. We performed an analysis of plasma levels of sTM in Thai patients with acute ischemic stroke and determined whether sTM levels correlate with stroke subtypes, severity, and risk factors. Ninety-three patients and 76 controls were enrolled. Blood samples were obtained within 24 hours after stroke onset. Plasma sTM levels, measured using quantitative enzyme-linked immunosorbent assay, were significantly higher in patients than controls (P < .005), with the mean ±standard deviation (SD) levels of 3.08 ± 1.05 and 2.57 ± 1.15 ng/mL, respectively. Plasma levels of sTM in patients with cardioembolic subtype were significantly higher than in patients with other stroke subtypes, with the mean ± SD levels of 3.79 ± 1.26, 2.38 ± 0.68 (P < .009), and 2.38 ± 0.44 (P < .05) ng/mL for cardioembolism, large artery atherosclerosis, and small artery occlusion, respectively. Plasma sTM levels were not associated with stroke severity and risk factors of stroke; however, there was a slight relationship between high sTM levels and the presence of atrial fibrillation in the patient group. In conclusion, plasma sTM levels were increased in Thai patients with cardioembolic stroke and may be a potential marker during the acute phase. © 2012 The Author(s). |
author2 |
Mahidol University |
author_facet |
Mahidol University Permphan Dharmasaroja Pornpatr A. Dharmasaroja Prasert Sobhon |
format |
Article |
author |
Permphan Dharmasaroja Pornpatr A. Dharmasaroja Prasert Sobhon |
author_sort |
Permphan Dharmasaroja |
title |
Increased plasma soluble thrombomodulin levels in cardioembolic stroke |
title_short |
Increased plasma soluble thrombomodulin levels in cardioembolic stroke |
title_full |
Increased plasma soluble thrombomodulin levels in cardioembolic stroke |
title_fullStr |
Increased plasma soluble thrombomodulin levels in cardioembolic stroke |
title_full_unstemmed |
Increased plasma soluble thrombomodulin levels in cardioembolic stroke |
title_sort |
increased plasma soluble thrombomodulin levels in cardioembolic stroke |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/14782 |
_version_ |
1763493077420343296 |